CSIMarket



China Biologic Products Holdings Inc   (CBPO)
Other Ticker:  
 

Cumulative China Biologic Products Holdings Inc 's Leverage Ratio for Trailing Twelve Months Period

CBPO's Leverage Ratio for Trailing Twelve Months Period and Total Liabilities, Equity growth


Select the Comparisons : Select the Ratio:

CBPO Leverage Ratio for Trailing Twelve Months Period

(Dec 31 2019)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2018)
IV. Quarter
Y / Y Equity Growth -3.79 % -3.79 % -3.79 % -3.79 % 177.68 %
Y / Y Total Liabilities Growth -43.39 % -43.39 % -43.39 % -43.39 % 36.55 %
Leverage Ratio for Trailing Twelve Months Period 0.09 0.11 0.12 0.14 0.16
Total Ranking # 175 # # # # 106
Seq. Equity Growth 0 % 0 % 0 % -3.79 % 0 %
Seq. Total Liabilities Growth 0 % 0 % 0 % -43.39 % 0 %


Leverage Ratio for Trailing Twelve Months Period Comment
On the trailing twelve months basis Due to debt repayement of 0% China Biologic Products Holdings Inc decreased Leverage Ratio for Trailing Twelve Months Period in the IV. Quarter to 0.09, a new company low.
Leverage Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies in Biotechnology & Pharmaceuticals industry 15 other companies have achieved lower Leverage Ratio for Trailing Twelve Months Period than China Biologic Products Holdings Inc . While Leverage Ratio for Trailing Twelve Months Period total ranking has deteriorated compare to previous quarter from to 175.

What is Leverage Ratio?
Who are CBPO's Customers?
Leverage Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 16
Sector # 56
S&P 500 # 172


Leverage Ratio for Trailing Twelve Months Period Statistics
High Average Low
0.62 0.28 0.09
(Dec. 30, 2014)   (Dec 31 2018)




Companies with similar average Leverage Ratio for Trailing Twelve Months Period for 12 months ending Dec 31 2019, within Biotechnology & Pharmaceuticals Industry Leverage Ratio for Trailing Twelve Months Period
Brickell Biotech Inc.  0.25 
Bluebird Bio Inc.  0.25 
Palisade Bio Inc.  0.24 
Adaptimmune Therapeutics Plc  0.24 
Salarius Pharmaceuticals inc.  0.23 
Oncternal Therapeutics Inc.  0.23 
Immunitybio inc.  0.22 
Arcus Biosciences Inc.  0.21 
Zai Lab Limited  0.20 
Crispr Therapeutics Ag  0.20 
Rubius Therapeutics Inc.  0.20 
Solid Biosciences Inc.  0.20 
Diffusion Pharmaceuticals Inc.  0.19 
Seagen Inc.  0.19 
Enzon Pharmaceuticals inc.  0.19 
Citius Pharmaceuticals Inc.  0.18 
Quince Therapeutics Inc.  0.18 
Protara Therapeutics Inc.  0.17 
Eyenovia inc.  0.17 
Unity Biotechnology Inc.  0.17 
Pharmacyte Biotech Inc.  0.16 
Procyon Corp  0.15 
Cytrx Corporation  0.14 
Atara Biotherapeutics Inc.  0.14 
Spero Therapeutics Inc.  0.14 
Catalyst Biosciences Inc.  0.14 
Pulse biosciences inc.  0.14 
Protokinetix Incorporated  0.12 
Organovo Holdings Inc.  0.12 
Lineage Cell Therapeutics Inc.  0.11 


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CATO's Profile

Stock Price

CATO's Financials

Business Description

Fundamentals

Charts & Quotes

CATO's News

Suppliers

CATO's Competitors

Customers & Markets

Economic Indicators

CATO's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2022 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071